ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1359	National Cancer Institute	Html	en	Cancer Pain (PDQ®)–Health Professional Version	Expert-reviewed information summary about pain as a complication of cancer or its treatment. Approaches to the management and treatment of cancer-associated pain are discussed.	initial pain assessment 0.567168 baseline pain intensity 0.558291 treats mild pain 0.559952 moderate cancer pain 0.617809 metastatic bone pain 0.57198 incident cancer pain 0.559612 acute pain resolves 0.55829 pain management treatment 0.568663 ongoing pain management 0.552517 pain relief ladder 0.55951 common cancer pain 0.591113 Neuropathic Pain sections 0.560808 somatic pain 0.561569 indicates mild pain 0.560721 cancer patients 0.628525 pain intensity 0.56637 pain management 0.652391 neuropathic pain 0.592568 Pain Symptom Manage 0.699092 cancer pain control 0.556765 Pain Management Nursing 0.556277 Pain Physician 0.561182 pain assessment 0.597079 Pain Palliat Care 0.567356 breakthrough cancer pain 0.563775	visceral pain signals 0.562249 severe cancer pain 0.582593 PUBMED Abstract 0.564761 visceral pain 0.565502 pain assessment toolkit 0.554382 mild pain 0.57672 Effective pain management 0.567467 cancer pain management 0.592002 pain relief 0.569023 moderate pain 0.568137 cancer pain 0.834476 American Pain Society 0.557173 pain 0.954306 acute pain 0.572092 Abstract 0.595673 Pain Med 0.572479 Clin Oncol 0.552396 severe pain 0.584777 cancer pain experience 0.579997 pain scale 0.566028 pain levels 0.565618 comprehensive pain assessment 0.576005 indicates moderate pain 0.564768 pain receptors 0.555011	CLICK HERE
1379	National Cancer Institute	Html	en	Cervical Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may increase the risk of developing cervical cancer and about approaches that may help in the prevention of this disease.	normal cervical cytology 0.510493 vaccine-treated women 0.487201 HPV types 0.757372 vaccine efficacy 0.741841 9-valent VLP vaccine 0.591937 vaccine-related HPV types 0.575946 prophylactic HPV vaccine 0.687205 HPV DNA testing 0.579437 vaccine efficacy rate 0.600644 persistent infection 0.526745 VLP vaccine 0.652393 HPV titers 0.562213 L1/2 HPV vaccines 0.566712 HPV type vs 0.562578 HPV-16/HPV-18 VLP vaccine 0.605344 pre-existing HPV infection 0.589015 cervical HPV DNA 0.601237 cervical cancers 0.492563 HPV-16/18 vaccine 0.555263 cervical cancer 0.587492 Rica Vaccine Trial 0.588987 nonvalent HPV vaccine. 0.569038 persistent HPV 0.541143 L1 VLP vaccine 0.61267	oncogenic HPV types 0.60386 two-dose schedule 0.501418 women 0.610755 9-valent HPV vaccine 0.681373 study 0.489719 HPV vaccination 0.541014 fully vaccinated women 0.493555 similar vaccine efficacy 0.608995 qHPV vaccine 0.557165 HPV vaccine 0.814126 true vaccine efficacy 0.62572 new vaccine 0.558251 12-month persistent infection 0.491511 invasive cervical cancer 0.57017 HPV infection offer 0.625011 common HPV types 0.578468 Vaccine efficacy rates 0.60682 9vHPV vaccine group 0.59158 bivalent HPV vaccine 0.686822 HPV infection 0.632752 vaccine 0.940033 placebo-controlled trial 0.490062 international randomized trial 0.490281 oncogenic types 0.491299	CLICK HERE
1415	National Cancer Institute	Html	en	Grief, Bereavement, and Coping With Loss (PDQ®)–Patient Version	Expert-reviewed report about grief, bereavement, and feelings of loss in survivors of someone who has died of cancer. Grief in children is also discussed.	normal grief process 0.471417 Common grief reactions 0.532686 grief pattern 0.454756 bereaved person moves 0.399208 family member 0.390974 PDQ cancer information 0.489866 unexpected loss 0.387668 loss 0.666269 children 0.561087 typical grief response 0.466341 PDQ Grief 0.446846 clinical trials 0.426876 grief 0.931776 anticipatory grief 0.60415 cancer information summary 0.442789 social support 0.46161 clinical trial 0.441424 younger bereaved people 0.426523 family members 0.386464 Grief bursts 0.441053 weight loss 0.372081 bereaved people 0.499808 severe grief 0.457196 difficult grief 0.440844	NCI PDQ cancer 0.383634 grief reactions 0.581886 person 0.556278 grief symptoms 0.442678 deceased person 0.373691 child 0.531789 distress 0.378808 normal grief 0.541883 death 0.826955 Chronic grief 0.43943 Cancer Information Service 0.369255 complicated grief 0.451713 National Cancer Institute 0.448538 health care 0.379094 grief process 0.5341 Palliative Care Editorial 0.392193 new treatment 0.370063 different cultures 0.372731 Care Editorial Board 0.393341 people 0.580964 way 0.395094 grief treatment 0.44457 comprehensive cancer information 0.368169 depression 0.378859	CLICK HERE
1732	National Cancer Institute	Html	en	Targeted Cancer Therapies	A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.	targeted therapies 0.916839 traditional chemotherapy drugs 0.434184 cancer vaccines 0.439223 cancer cells 0.924402 new blood vessel 0.443884 leukemic cells 0.432134 angiogenesis inhibitors 0.440608 Targeted cancer therapies 0.81804 fact sheets Cancer 0.457828 cancer cell growth 0.589511 specific cancer cells 0.553642 gene expression modulators 0.438407 pancreatic cancer 0.4493 hormone therapies 0.533362 specific target protein 0.46382 differentially expressed target 0.440917 nci-supported clinical trials 0.437017 molecularly targeted drugs 0.562455 clinical trials 0.591045 tumor cells 0.46028 normal cells 0.520102 targeted therapy 0.645434 specific targeted therapy 0.552585 breast cancer 0.484727	Biological Therapies 0.463149 growth factor receptor 0.473185 cancerous cells 0.44351 cancer development 0.434952 experimental targeted therapies 0.619071 targeted therapy trastuzumab 0.545984 Keytruda®) 0.487223 specific types 0.440167 prostate cancer 0.45274 cancer clinical trials 0.499699 tumor cell proliferation 0.433817 certain cancer types 0.465459 high blood pressure 0.438907 metastatic breast cancer 0.450488 particular targeted therapy 0.540161 epidermal growth factor 0.475814 specific molecular targets 0.438616 signal transduction inhibitors 0.526574 potential targets 0.462585 certain immune cells 0.461941 (Rituxan Hycela™) 0.432805 different targeted therapies 0.660128 monoclonal antibodies 0.565531	CLICK HERE
1735	National Cancer Institute	Html	en	Reproductive History and Cancer Risk	A fact sheet that describes what is known about the relationship between pregnancy, miscarriage, abortion, fertility treatment and the risk of cancer.	spontaneous abortion 0.436313 additional full-term pregnancy 0.438399 reproductive factors 0.477411 British Journal 0.464068 Breast Cancer Research 0.554497 Long-term cancer risk 0.463368 reduced risk 0.446487 ovarian cancer 0.487507 Smalley M. Pregnancy 0.434754 future breast cancer 0.499324 pregnancy 0.509986 lower risk 0.435353 cancer types 0.43982 receptor-negative breast cancer 0.516576 maternal breast cancer 0.498304 slightly higher risk 0.457714 Cancer Epidemiology 0.469709 ovarian stimulation 0.442204 breast cancer declines 0.516281 endometrial cancer 0.444521 International Journal 0.437218 women 0.502711 risk reduction 0.435107 ovarian hormones 0.434429 invasive ovarian cancer 0.459634	breast cells 0.485604 decreased risk 0.446489 cancer cells 0.451518 Breast cancer incidence 0.495609 full-term pregnancy 0.496243 Endocrine-Related Cancer 0.440218 breast tissue 0.475053 studies 0.44347 epithelial ovarian cancer 0.455081 ovarian cancer risk 0.471705 epidemiological studies 0.438401 higher risk 0.46047 endocrine-related risk factors 0.447705 breast cancer risk 0.823683 receptor–positive breast cancer 0.54092 breast cancer 0.983763 van leeuwen fe 0.44337 pregnancy-related factors 0.45934 vitro fertilization 0.434549 Colditz GA 0.436762 fertility drugs 0.477238 receptor–negative breast cancers 0.493334 et al 0.597414 Vatten LJ 0.446247	CLICK HERE
1802	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin en adultos.	after treatment 0.32907 hodgkin's disease 0.974381 risk after 0.31263 lymphocyte predominant hodgkin 0.318894 prognostic factors 0.314973 limited stage hodgkin 0.313655 early-stage hodgkin 0.357479 following hodgkin 0.342696 Lymphoma Study Group 0.312404 Hodgkin's Study 0.313145 lymphocyte-predominant hodgkin 0.411856 Radiat Oncol Biol 0.313583 Hodgkin lymphoma patients 0.316654 Natl Cancer Inst 0.33424 lymphocyte-predominant hodgkin disease 0.363459 survivors after hodgkin 0.311932 from hodgkin 0.320125 lymphoma treated with 0.313078 patients with 0.322542 risk following hodgkin 0.312032 leukemia following hodgkin 0.320131 hodgkin's lymphoma 0.767848 lymphocyte-rich classical hodgkin 0.31922 Hodgkin's lymphoma treated 0.328493 Hodgkin Lymphoma study 0.318752	ia lymphocyte-predominant hodgkin 0.311912 german hodgkin study 0.412479 after hodgkin 0.345197 nodular lymphocyte-predominant hodgkin 0.337091 hodgkin study group 0.386928 with hodgkin 0.364083 early stage hodgkin 0.311698 advanced hodgkin 0.325939 Hodgkin's Disease Staging 0.316019 with classical hodgkin 0.313045 advanced hodgkin disease 0.325216 EORTC Lymphoma 0.311774 elderly hodgkin 0.312531 Clin Oncol 0.703258 German Hodgkin Lymphoma 0.326196 patients treated 0.312778 Oncol Biol Phys 0.313852 Hodgkin lymphoma treated 0.316446 hodgkin lymphoma 0.74467 lymphocyte-predominant hodgkin lymphoma 0.4086 Hodgkin's Disease Cancer 0.321788 classical hodgkin lymphoma 0.356483 cancer risk 0.335147 lymphocyte-depleted classical hodgkin 0.313017	CLICK HERE
3421	National Cancer Institute	Html	es	Antioxidantes y prevención del cáncer	Antioxidants are substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer. Antioxidants interact with and stabilize free radicals and may prevent some of the damage fre	nutrition intervention trial 0.318966 Population Nutrition Intervention 0.307215 Minerales Antioxidantes 0.329026 mortality during 0.312847 skin cancers 0.309111 Hercberg S 0.31386 complementos antioxidantes alimenticios 0.358441 vitamina c 0.306663 vitamina a 0.307237 Klein EA 0.307093 vitamina e 0.306864 Virtamo J 0.307865 mortality after 0.306705 antioxidantes alimenticios 0.533634 stopping antioxidant vitamins 0.315828 Internal Medicine 0.308526 Estados Unidos 0.333664 antioxidant vitamins 0.315879 PubMed Abstract 0.94039 Estudio Demográfico 0.30775 follow-up after stopping 0.328778 after stopping antioxidant 0.315902 skin cancers during 0.306731 minerales selenio 0.30885 health beneficial effects 0.308495	randomized controlled 0.317735 International Journal 0.310662 health effects 0.306579 Kristal AR 0.308705 tomar complementos 0.660547 Taylor PR 0.316391 Ezzedine K 0.307269 general population 0.307041 supplemental alpha-tocopherol 0.309241 Kesse-Guyot E 0.307458 tract cancers 0.32431 médicos varones 0.307704 beta carotene 0.315537 elemento mineral selenio 0.311109 Cancer Prevention Study 0.31922 Cancer Prevention Trial 0.339926 complementos alimenticios 0.353561 retinol efficacy trial 0.343648 SU.VI.MAX Study 0.30914 radicales libres 0.808852 resultados mixtos 0.310828 Cancer Institute 0.352968 New England Journal 0.317494 Cancer Prevention 0.362527	CLICK HERE
3565	National Cancer Institute	Html	en	Funding Opportunities	Find a wide range of funding announcements to support cancer research and training, organized by topic and by funding mechanism.	population sciences 0.493717 promising research areas 0.56879 research grants 0.500944 AIDS-related cancer 0.494918 Cancer Clinical Proteomics 0.567175 Cancer Complementary 0.503257 mutant RAS-driven cancers 0.494379 Cancer Moonshot Blue 0.59594 Cancer Nanotechnology Research 0.679363 Cancer program 0.497422 research community 0.507936 cancer patients 0.484719 Research projects 0.502551 Basic cancer research 0.680007 Tissue Sample Collection 0.485994 Reduce Cancer Health 0.579079 Trans-NIH Research Project 0.629695 Cancer Health Disparities 0.713271 surveillance cancer research 0.666086 basic cancer biology 0.601818 Cancer Control 0.538781 biostatistical funding opportunities 0.51758 Cancer Moonshotâ„  Funding 0.624526 Ribbon Panel recommendations 0.479686	cancer prevention 0.563482 Cancer Treatment 0.485294 epidemiological research 0.487712 alternative medicine practice 0.49686 NCI Alliance 0.464504 Provocative Questions Program 0.51458 cancer research 0.973473 treat cancer 0.476905 recent NCI-supported RFAs 0.522382 cancer screening procedures 0.560144 alternative medicine 0.550525 Analysis Technologies Program 0.493099 small business 0.635559 private sector participation 0.462098 health disparities perspective 0.521069 RAS Initiative enlists 0.522897 Outstanding Investigator Award 0.657445 NCI initiative 0.486583 Biospecimen Research Branch 0.595175 Business Innovation Research 0.566067 Translational Research 0.497403 Business Technology Transfer 0.60463 Small Business Technology 0.604737 research communities 0.503329	CLICK HERE
16662	National Cancer Institute	Html	es	Qué son el “cerebro en quimio” y el deterioro cognoscitivo después de tratamiento de cáncer	Actualización acerca de la investigación de los factores que tienen una función en el	gen apoe 0.427379 información meses 0.42886 ¿estos problemas 0.43724 doctor ahles 0.800077 peor desempeño 0.428323 recientes investigaciones 0.427457 gemelos idénticos —una 0.452424 larga duración 0.464561 cuáles pacientes 0.458793 edad afín 0.424345 variado deterioro 0.472498 Wilmot Cancer Institute 0.444334 Funciones Cognoscitivas 0.442034 gen bdnf 0.427202	doctor tim ahles 0.462437 oncológico integral jonsson 0.458544 llamada evaluación funcional 0.440824 antidepresivo fluoxetina 0.426333 sistema nervioso central 0.4425 doctora rowland 0.544141 actividad neurotransmisor 0.425054 doctora patricia ganz 0.777152 Oncológico Memorial Sloan 0.455699 doctora julia rowland 0.500519 quimioterapia 5-FU 0.47139 doctora michelle janelsins 0.489763 gen comt 0.425879	CLICK HERE
17188	National Cancer Institute	Html	en	Fertility Issues in Boys and Men with Cancer	Fertility issues are common in boys and men getting cancer treatment. Fertility preservation options include sperm banking, testicular shielding, testicular sperm extraction (TESE), and testicular tissue freezing. Support and clinical trials are listed.	Sexual Health Issues 0.508548 cancer treatment 0.619036 fertility 0.97146 baseline fertility 0.628851 family member 0.464194 cancer therapy 0.481706 health care team 0.501109 sperm counts 0.505642 fertility problems 0.606189 stem cell transplants 0.576694 upsetting long-term effects 0.50079 Sperm banking 0.500128 Testicular tissue freezing 0.505046 specific treatment 0.473076 fertility clinic 0.610475 professionally led support 0.49722 sperm-forming cells 0.50982 reproductive endocrinologist 0.471953 fertility options 0.634938 fertility preservation procedures 0.624595 Testicular sperm extraction 0.553558 radiation therapy 0.551741 testicular shielding 0.519544 sperm cells 0.508932 Reproductive Medicine 0.463459	cancer treatments 0.62693 blood stem cell 0.500463 personal health factors 0.507399 fertility preservation options 0.794614 testicular tissue cryopreservation 0.506676 scatter radiation 0.468354 male cancer patients 0.603613 fertility preservation 0.823931 young male cancer 0.600402 fertility risks 0.574477 LIVESTRONG Fertility 0.586472 rectal cancer 0.479468 reproductive age 0.463816 sperm 0.578609 infertility 0.495824 doctor 0.471639 fertility specialist 0.642942 reproductive medical information 0.506006 cancer 0.662671 fertility preservation clinic 0.634592 fertility preservation discounts 0.62021 bone marrow transplants 0.501862 child’s doctor 0.462088 reproductive organs 0.558126	CLICK HERE